Phase IIa trial assessing the tolerability of oral insulin [ORMD 0801] in patients with type 1 diabetes mellitus
Phase of Trial: Phase II
Latest Information Update: 29 Apr 2013
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- Sponsors Oramed Pharmaceuticals
- 29 Apr 2013 Results presented at the Global Technology Community Diabetes Summit 2013, according to an Oramed Pharmaceuticals media release.
- 28 Jun 2010 Results reported at the 2010 Scientific Sessions of the American Diabetes Association (ADA), according to an Oramed Pharmaceuticals media release.
- 22 Jul 2009 New trial record.